metabolic drugs

Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b
Biotech

Barinthus enters reverse merger with metabolic disease biotech

The merged entity will work to advance Clywedog’s diabetes portfolio plus Barinthus’ immunology and immunology program.
Gabrielle Masson Sep 30, 2025 10:39am
Illustration of the concept of layoff and downsizing of staff

Biomea cuts staff, drops leukemia asset in metabolic shift

May 5, 2025 6:59pm
deal handshake biotech deal pharma deal biopharma deal

Novo taps Photys for multi-molecule cardiometabolic collab

Dec 18, 2024 7:30am
proclaim red announcement

Aligos MASH prospect slashes liver fat in phase 2

Sep 19, 2024 1:00pm
close-up image of an eye

Skye ends eye disease R&D after glaucoma drug's phase 2 fail

Jun 10, 2024 8:51am
liver disease fibrosis NASH NAFLD cancer cirrhosis liver

Chinese biotech's MASH drug reduces liver fat in phase 2 trial

Mar 18, 2024 11:07am